FDA wants to hear your thoughts on advisory committees

STAT April 30, 2024
Elaine Chen

Hello, I’m up bright and early today to report on earnings, with the help of some coffee (with pasteurized milk) and the soundtrack for the new Challengers movie.

And if you haven’t yet, please fill out this survey so we can keep making this newsletter more useful for you!

Lilly raises 2024 guidance even with supply constraints

Here are the main results from Lilly’s earnings this morning:

• Raised adjusted earnings guidance for 2024 to a range of $13.50 to $14.00 per share, up from a prior forecast of $12.20 to $12.70 per share
• Q1 earnings were $2.58 share, beating expectations of $2.39 per share
• The obesity drug Zepbound brought in $517 million in Q1 sales, more than the $389...

Today's Sponsors

Today's Sponsor